Ethylene Glycol

Ethylene Glycol

SCHEMBL3359591

C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.C=C.OCCO

nearest known ligand 0.71

Full drug profile on Sugi Atlas →

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
TSHR P16473 5/20 0.71
ALDH1A1 P00352 2/20 0.36
TDP1 Q9NUW8 1/20 0.31
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ethylene Glycol SCHEMBL5831013 1.00 TSHR (0.71) TSHRALDH1A1TDP1MAPK1
Ethylene Glycol SCHEMBL20501 1.00 TSHR (0.71) TSHRALDH1A1TDP1MAPK1
Ethylene Glycol SCHEMBL5145867 1.00 TSHR (0.71) TSHRALDH1A1TDP1MAPK1
Ethylene Glycol SCHEMBL651562 1.00 TSHR (0.71) TSHRALDH1A1TDP1MAPK1
Ethylene Glycol SCHEMBL2954500 1.00 TSHR (0.71) TSHRALDH1A1TDP1MAPK1
Ethylene Glycol SCHEMBL3486924 1.00 TSHR (0.71) TSHRALDH1A1TDP1MAPK1
Ethylene Glycol SCHEMBL9768800 1.00 TSHR (0.71) TSHRALDH1A1TDP1MAPK1
Ethylene Glycol SCHEMBL9754823 1.00 TSHR (0.71) TSHRALDH1A1TDP1MAPK1
Ethylene Glycol SCHEMBL20610891 1.00 TSHR (0.71) TSHRALDH1A1TDP1MAPK1
Ethylene Glycol SCHEMBL15813205 1.00 TSHR (0.71) TSHRALDH1A1TDP1MAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 152 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4732841-A1 FOAM SCLEROSANT COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF Jenkem Technology Co., Ltd. (Beijing) (CN) 2026-04-29 EP claimed
US-12054648-B2 Adhesive composition LG CHEM, LTD. (KR) 2024-08-06 US claimed
EP-4732841-A1 FOAM SCLEROSANT COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF Jenkem Technology Co., Ltd. (Beijing) (CN) 2026-04-29 EP disclosed
US-12588548-B2 Resin composition for semiconductor sealing, underfill material, mold resin, and semiconductor package SEKISUI KASEI CO., LTD. (JP) 2026-03-24 US disclosed
US-12545754-B2 Polymer particles, thickener, and composition SEKISUI KASEI CO., LTD. (JP) 2026-02-10 US disclosed
CN-120202529-A Curable composition, film forming method, pattern forming method, and article manufacturing method 佳能株式会社 2025-06-24 CN disclosed
US-12325766-B2 Fine resin particles and method for producing the same SEKISUI KASEI CO., LTD. (JP) 2025-06-10 US disclosed
US-12284755-B2 Laminate, laminate with buildup layer, laminate with metal foil, and circuit board SEKISUI KASEI CO., LTD. (JP) 2025-04-22 US disclosed
CN-119596642-A Curable composition, film forming method and manufacturing method 佳能株式会社 2025-03-11 CN disclosed
WO-2025022881-A1 CURABLE COMPOSITION, FILM FORMING METHOD, AND METHOD FOR PRODUCING ARTICLE キヤノン株式会社 2025-01-30 WO disclosed
CN-119343746-A Curable composition, reverse pattern forming method, film forming method, and article manufacturing method 佳能株式会社 2025-01-21 CN disclosed
EP-0941087-A1 TOPICAL FORMULATIONS CONTAINING AS A THERAPEUTIC ACTIVE AGENT FATTY ACIDS OR FATTY ALCOHOLS OR MONOGLYCERIDE DERIVATIVES THEREOF FOR TREATING OF MUCOSA INFECTIONS Thormar, Halldor (IS) 1999-09-15 EP disclosed
EP-0930173-A1 Thermal transfer method using a thermal transfer sheet and thermally transferred product DAI NIPPON PRINTING CO., LTD. (JP) 1999-07-21 EP disclosed
EP-0917964-A2 Protective layer transfer sheet DAI NIPPON PRINTING CO., LTD. (JP) 1999-05-26 EP disclosed
US-5837648-A Thermal transfer sheet, thermal transfer method using the same, and thermally transferred product DAI NIPPON PRINTING CO., LTD. (JP) 1998-11-17 US disclosed
WO-1998020872-A1 TOPICAL FORMULATIONS CONTAINING AS A THERAPEUTIC ACTIVE AGENT FATTY ACIDS OR FATTY ALCOHOLS OR MONOGLYCERIDE DERIVATIVES THEREOF FOR TREATING OF MUCOSA INFECTIONS THORMAR HALLDOR (IS) 1998-05-22 WO disclosed
EP-0677397-B1 Protective layer transfer film and image-printed matter DAINIPPON PRINTING CO LTD (JP) 1997-11-12 EP disclosed
EP-0743194-A1 Thermal transfer sheet, thermal transfer method using same, and thermally transferred product DAI NIPPON PRINTING CO., LTD. (JP) 1996-11-20 EP disclosed
US-5494885-A THERMAL PRINTING WITH COPOLYMER HAVING ULTRAVIOLET-ABSORBING MONOMER; CHEMICAL, WEAR, SOLVENT, LIGHT AND WEATHER RESISTANT DAI NIPPON PRINTING CO., LTD. (JP) 1996-02-27 US disclosed
EP-0677397-A1 Protective layer transfer film and image-printed matter DAI NIPPON PRINTING CO., LTD. (JP) 1995-10-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12588548-B2 Resin composition for semiconductor sealing, underfill material, mold resin, and semiconductor package SEM1, ASH2L, MARS1 TSHR 4507/4885ALDH1A1 682/4885TDP1 1635/4885
US-12545754-B2 Polymer particles, thickener, and composition LCP1, PCBP1, COL1A1 TSHR 4336/4885ALDH1A1 1847/4885TDP1 333/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.